CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 136 enrolled
Drug / intervention
VLNC cigarettes +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02000921
NCT02000921N/ACompleted
CompareCT.gov

Models for Tobacco Productive Evaluation: Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors

University of Minnesota·interventional·Posted Dec 4, 2013·Updated Mar 31, 2017

In Brief

A clinical study evaluating VLNC cigarettes, Combusted Products, and 2 other interventions for Tobacco Addiction and Dual Tobacco Use. Completed, enrolled 136 participants across 1 site.

Detailed Summary

The main focus of this study is to determine the use of nicotine-containing products across the three experimental conditions. Subjects will be monitored to determine their continued use of assigned cigarettes, switching to other combusted and/or non-combusted tobacco, or cessation of all tobacco containing products.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Addiction, Dual Tobacco Use
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 4, 2013
Enrollment StartDec 1, 2013
Primary CompletionSep 1, 2015
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 12.6 years ago

Interventions

VLNC cigarettesother

Modified risk tobacco product

Combusted Productsother

Options for combusted tobacco products include cigars, cigarillos, and little cigars, .

Non-combusted productsother

Options for non-combusted tobacco products include smokeless tobacco, novel snus products, e-cigarettes and medicinal nicotine.

CN cigarettesother

Experimental cigarettes with conventional nicotine content.